Paracrine release of insulin-like growth factor 1 from a bioengineered tissue stimulates skeletal muscle growth in vitro

Tissue Engineering

Volumn 12, Issue 7, 2006, Pages 1833-1841

  Shansky, Janet ^a   Creswick, Bernard ^a   Lee, Peter ^a   Wang, Xiao ^a   Vandenburgh, Herman ^a  

^a MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; GROWTH KINETICS; INSULIN; MUSCULOSKELETAL SYSTEM; PROTEINS;

BIOCHAMBERS; MYOBLASTS; MYOFIBERS; NONTRANSDUCED CONTROL;

TISSUE;

GROWTH FACTOR; RECOMBINANT PROTEIN; RETROVIRUS VECTOR; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; BIOARTIFICIAL ORGAN; BIOENGINEERING; CELL PROLIFERATION; GENETIC ENGINEERING; MUSCLE ATROPHY; MUSCLE GROWTH; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; SKELETAL MUSCLE; TISSUE ENGINEERING;

ANIMALS; BIOREACTORS; CHICK EMBRYO; INSULIN-LIKE GROWTH FACTOR I; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; PARACRINE COMMUNICATION; TISSUE ENGINEERING; TRANSDUCTION, GENETIC;

AVES; MURINAE;

EID: 33746693047     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.1833     Document Type: Article

References (31)

1. Rennie, M.J., Wackerhage, H., Spangenburg, E.E., and Booth, F.W. Control of the size of the human muscle mass. Annu. Rev. Physiol. 66, 799, 2004.
2. Glass, D.J. Signaling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5, 87, 2003.
3. Guttridge, D.C. Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care 7, 443, 2004.
4. Sacheck, J.M., Ohtsuka, A., McLary, S.C., and Goldberg, A.L. IGF-1 stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am. J. Physiol. Endocrinol. Metab. 287, E591, 2004.
5. LeRoith, D. Non-islet cell hypoglycemia. Ann. Endocrinol. (Paris) 65, 99, 2004.
6. Adams, G.R., and McCue, S.A. Localized infusion of IGF-1 results in skeletal muscle hypertrophy in rats. J. Appl. Physiol. 84, 1716, 1998.
7. Barton-Davis, E.R., Shoturma, D.I., Musaro, A., Rosenthal, N., and Sweeney, H.L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. USA 95, 15603, 1998.
8. Lu, Q.L., Bou-Gharios, G., and Partridge, T.A. Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther. 10, 131, 2003.
9. Blau, H.M., and Springer, M.L. Gene therapy-A novel form of drug delivery. N. Engl. J. Med. 333, 1204, 1995.
10. VandenDriessche, T., Thorrez, L., Naldini, L., Follenzi, A., Moons, L., Berneman, Z., Collen, D., and Chuah, M.K. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100, 813, 2002.
11. Vandenburgh, H., Del Tatto, M., Shansky, J., Goldstein, L., Russell, K., Genes, N., Chromiak, J., and Yamada, S. Attenuation of skeletal muscle wasting with recombinant human growth hormone secreted from a tissue-engineered bioartificial muscle. Hum. Gene Ther. 9, 2555, 1998.
12. Lu, Y., Shansky, J., Del Tatto, M., Ferland, P., Wang, X., and Vandenburgh, H. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 104, 594, 2001.
13. Lu, Y., Shansky, J., Del Tatto, M., Ferland, P., McGuire, S., Marszalkowski, J., Maish, M., Hopkins, R., Wang, X., Kosnik, P., Nackman, M., Lee, A., Creswick, B., and Vandenburgh, H. Therapeutic potential of implanted tissue-engineered bioartificial muscles delivering recombinant proteins in the sheep heart. Ann. NY Acad. Sci. 961, 78, 2001.
14. Brimah, K., Ehrhardt, J., Mouly, V., Butler-Browne, G.S., Partridge, T.A., and Morgan, J.E. Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors. Hum. Gene Ther. 15, 1109, 2004.
15. Zdanowicz, M.M., and Teichberg, S. Effects of insulin-like growth factor-1/binding protein-3 complex on muscle atrophy in rats. Exp. Biol. Med. 228, 891, 2003.
16. Shansky, J., and Vandenburgh, H. Stimulation of skeletal muscle growth by the paracrine release of IGF-1 from an engineered tissue. Am. Soc. Grav. Space Biol. Bull. 18, 63, 2004.
17. Miller, A.D., Miller, D.G., Garcia, J.V., and Lynch, C.M. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217, 581, 1993.
18. Tobias, C.A., Kim, D., and Fischer, I. Improved recombinant retroviral titers utilizing trichostatin A. BioTechniques 29, 884, 2000.
19. Vandenburgh, H.H., Karlisch, P., and Farr, L. Maintenance of highly contractile skeletal myotubes in collagen gels. In Vitro Cell. Dev. Biol. 24, 166, 1988.
20. Vandenburgh, H.H., Del Tatto, M., Shansky, J., LeMaire, J., Chang, A., Payumo, F., Lee, P., Goodyear, A., and Raven, L. Tissue engineered skeletal muscle organoids for reversible gene therapy. Hum. Gene Ther. 7, 2195, 1996.
21. Springer, M.L., and Blau, H.M. High-efficiency retroviral infection of primary myoblasts. Somat. Cell Mol. Genet. 23, 203, 1997.
22. Vandenburgh, H.H., Swasdison, S., and Karlisch, P. Computer aided mechanogenesis of skeletal muscle organs from single cells in vitro. FASEB J. 5, 2860, 1991.
23. Chromiak, J.A., Shansky, J., Perrone, C., and Vandenburgh, H.H. Bioreactor perfusion system for the long-term maintenance of tissue-engineered skeletal muscle organoids. In Vitro Cell. Dev. Biol. Anim. 34, 694, 1998.
24. Vandenburgh, H.H., Karlisch, P., and Solerssi, R. Insulin and insulin-like growth factor-1 stimulation of skeletal myofiber growth in vitro is enhanced by mechanical activity. J. Cell Biol. 115, 221a, 1991.
25. Vandenburgh, H., Chromiak, J., Shansky, J., DelTatto, M., and LeMaire, J. Space travel directly induces skeletal muscle atrophy. FASEB J. 13, 1031, 1999.
26. Edgerton, V.R., and Roy, R.R. Adaptations of skeletal muscle to space flight. In: Churchill, S., eds. Fundamentals of Space Life Sciences. Melbourne, FL: Krieger, 1997, pp. 105-120.
27. Grindeland, R.E., Roy, R., Edgerton, V.R., Grossman, E., Rudolph, I., Pierotti, D., and Goldman, B. Exercise and growth hormone (GH) have synergistic effects on skeletal muscle and tibias of suspended rats. FASEB J. 5, A1037, 1991.
28. Hintz, R.L. Current and potential therapeutic uses of growth hormone and insulin-like growth factor 1. Endocrinol. Metabol. Clin. North Am. 25, 759, 1996.
29. Vandenburgh, H.H., Karlisch, P., Shansky, J., and Feldstein, R. Insulin and insulin-like growth factor-1 induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am. J. Physiol. (Cell Physiol. 29) 260, C475, 1991.
30. Chromiak, J., Shansky, J., Perrone, C.E., and Vandenburgh, H.H. Bioreactor perfusion system for the long term maintenance of tissue-engineered skeletal muscle organoids. In Vitro Cell. Dev. Biol. 34, 694, 1998.
31. Huang, Y.C., Dennis, R.G., Larkin, L., and Baar, K. Rapid formation of functional muscle in vitro using fibrin gels. J. Appl. Physiol. 98, 706, 2005.